Walgreens Ends Relationship With Theranos in Latest Blow For Startup

Walgreens Ends Relationship With Theranos in Latest Blow For Startup
Image credit: Justin Sullivan | Getty Images

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!
2 min read
This story originally appeared on CNBC

Drugstore chain said on Sunday it would end its relationship with , in another blow for the blood-testing company that was once lauded for its innovative approach but has increasingly come under scrutiny.

Walgreens said it would shutter all 40 Theranos Wellness Centers at its stores in , having already stopped Theranos laboratory testing services at its location in , Calif.

The latest announcement meant Walgreens would no longer offer Theranos services at any of its stores.

"In light of the voiding of a number of test results, and as the Centers for and Medicaid Services (CMS) has rejected Theranos' plan of correction and considers sanctions, we have carefully considered our relationship with Theranos and believe it is in our customers' best interests to terminate our partnership," Brad Fluegel, Walgreens senior vice president and chief commercial market development officer, said in a statement.

In a statement, a Theranos spokesperson said the company is working closely with officials to ensure it not only complies with all federal regulations but exceeds them.

"We are disappointed that Walgreens has chosen to terminate our relationship and remain fully committed to our mission to provide patients access to affordable health information and look forward to continuing to serve customers in Arizona and through our retail locations," the spokesperson said.

Theranos was once praised for its fast, less-invasive blood testing technology but the company has found itself in the spotlight after media reports raised questions about the accuracy of its proprietary tests.

Federal prosecutors from the U.S. Attorney's office and the SEC have investigated Theranos over whether it misled investors, The  reported in April.

Theranos also faced allegations that most of its tests were in fact performed with traditional lab machines, not its proprietary Edison device, prompting potential sanctions against the company's CEO, Elizabeth Holmes. The WSJ reported in May that Theranos had voided all results for Edison-device tests conducted in 2014 and 2015.

More from Entrepreneur

Get heaping discounts to books you love delivered straight to your inbox. We’ll feature a different book each week and share exclusive deals you won’t find anywhere else.
Jumpstart Your Business. Entrepreneur Insider is your all-access pass to the skills, experts, and network you need to get your business off the ground—or take it to the next level.
Discover a better way to hire freelancers. From business to marketing, sales, finance, design, technology, and more, we have the freelancers you need to tackle your most important work and projects, on-demand.

Latest on Entrepreneur